The emergence of the tumor cell-targeted apoptotic protein complex marked a new step forward in tumor treatment at Sanbo Hospital. Phase I animal experiments achieved success, and Phase II and Phase III animal experiments are scheduled. After animal trials, clinical trials will follow. If the treatment effect of this new protein complex can be stabilized, its application in the clinic is very probable, which is an exciting piece of news.
With Sanbo Hospital currently developing at a high speed, Dean Xia felt a bit anxious. What he sees is not the present, but ten or twenty years later, and where the path of Sanbo Hospital should lead. He wants to lay a solid foundation for Sanbo Hospital now, allowing it to continue stable development and not be just a fleeting success.
